
Stevenage Bioscience Catalyst is a leading location for companies to develop and commercialise cutting edge therapeutics.
The Campus is home to major organisations including GSK, the Cell & Gene Therapy Manufacturing Catapult, LifeArc and GE alongside a growing cluster of academics and start-up companies which together have raised over £1bn in funding.
The facilities have been designed to foster cooperation, scientific and commercial dialogue and interaction between entrepreneurs. Access is offered to business support, equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies.
Location: United Kingdom, England, Stevenage
Employees: 1-10
Founded date: 2012
Investment Type: Accelerator
Mentions in press and media 12
Date | Title | Description | Source |
02.03.2022 | Stevenage Bioscience Catalyst launches accelerator programme... | Stevenage Bioscience Catalyst (SBC) launches an accelerator programme to give start-ups working on d... | cambridgen... |
09.12.2021 | Report demonstrates Stevenage Bioscience Catalyst’s key role... | Report demonstrates Stevenage Bioscience Catalyst’s key role in delivering the economic benefit from... | cambridgen... |
18.11.2021 | Biotech start-ups successfully graduate from DATA accelerato... | Biotech start-ups successfully graduate from DATA accelerator programme at Stevenage Bioscience Cata... | cambridgen... |
23.02.2021 | Stevenage Bioscience Catalyst launches accelerator programme... | Stevenage Bioscience Catalyst launches accelerator programme for biotech start-ups 23-02-2021 Stev... | cambridgen... |
03.01.2021 | Dr Sally Ann Forsyth CEO Stevenage Bioscience Catalyst award... | Dr Sally Ann Forsyth CEO Stevenage Bioscience Catalyst awarded OBE 03-01-2021 Dr Sally Ann Forsyth... | cambridgen... |
24.11.2020 | Stevenage Bioscience Catalyst opens the Lab Hotel | Stevenage Bioscience Catalyst opens the Lab Hotel 24-11-2020 Stevenage Bioscience Catalyst (SBC), ... | cambridgen... |
01.09.2020 | SBC company ReViral raises $44 million in Series C financing | SBC company ReViral raises $44 million in Series C financing 01-09-2020 London & Research Tria... | cambridgen... |
05.01.2017 | NeRRe Therapeutics Raises £23M in Series B Financing | NeRRe Therapeutics, a Stevenage, England, UK-based clinical-stage company, raised £23m in Series B f... | finsmes.co... |
16.10.2013 | MRC Technology to join innovation network at Stevenage Biosc... | MRC Technology to join innovation network at Stevenage Bioscience Catalyst 16-10-2013 Stevenage Bi... | cambridgen... |
30.09.2013 | Learn about biobusiness innovation in a cluster | Learn about biobusiness innovation in a cluster 30-09-2013 Hear Jane Osbourn, Site Leader, Vice Pr... | cambridgen... |
Show more